Primary Site >> Biliary tract Cancer

Gene >> ERBB3

  • 2012
  • 2014
  • 2016
  • 2017
  • 2018
Ref: HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.
PMID: 23052372
Ref: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
PMID: 24563076
Ref: Characterization of EGFR family gene aberrations in cholangiocarcinoma.
PMID: 24927194
Ref: miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.
PMID: 24966896
Ref: Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.
PMID: 24997986
Ref: Pertuzumab in gastrointestinal cancer.
PMID: 26619359
Ref: HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
PMID: 27981460
Ref: The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
PMID: 28285962
Ref: Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.
PMID: 28671339
Ref: Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.
PMID: 29954840
Ref: The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.
PMID: 30335866